After a painfully quiet 2016, initial public offerings both current and future have rebounded with gusto through the first four months of 2017.
So far, 45 IPOs have priced this year – nearly three times as many as at this point last year, according to Renaissance Capital, which tracks initial offerings.
The rebound started with Snap Inc. (NYSE: SNAP)’s $3.4 billion IPO in March – and has been followed up by offerings from the likes of Cloudera Inc. (NYSE: CLDR), Okta Inc. (Nasdaq: OKTA), and Mulesoft Inc. (NYSE: MULE).
And now the trend has spread to Canada – specifically its legal marijuana companies. This marries the fastest growing Frontier Investing sector with the most exciting investment play Wall Street has to offer the typical investor.
The IPO I’m watching closest right now – the one I find most intriguing – is going live later this month.
It’s a licensed medical marijuana grower/dispensary.
And it’s worlds beyond most other marijuana companies that have recently gone public or are preparing to do so.
In fact, it’s already performing better financially than the vast majority of marijuana companies already trading on exchanges throughout the world.
And it could turn $50 into $50,000.
You can find out how in a new report we’re releasing following tonight’s FREE Pot Stock Briefing.
That Briefing is TONIGHT at 6 p.m. ET.
If you want to attend, you must make a reservation with us ASAP. We’re going live in just a few hours.
It costs nothing – so the only thing you have to lose is the latest and best information on the fastest-growing biotech sector in North America.
Click here to save your spot before it’s too late. My team will follow up right away with all the details you’ll need on how to attend.